Enter Note Done
Go to previous page in this tab
Event
  • Scientific Session
  • Bookmark Icon
  • The Use of NAMs in Food Safety: State of Practice and Opportunities for New Science
  • Schedule
    Notes
  • Stars at Night Ballroom B1‚ Convention Center
    Set Timezone


Chair: Kevin Boyd, The Hershey Company
Co-Chair: Ivan Rusyn, Texas A&M University

Primary Endorser: Food Safety Specialty Section


Endorser(s): Regulatory and Safety Evaluation Specialty Section


Endorser(s): In Vitro and Alternative Methods Specialty Section


The landscape of food safety assessment is undergoing a paradigm shift as regulatory agencies, industry, and scientific communities work toward improving human health while minimizing and ultimately replacing animal testing, driven by scientific advancement, ethical considerations, and regulatory mandates across global jurisdictions. This transformation requires not only the development of novel methodologies but also fundamental changes in how we generate, evaluate, and integrate evidence for safety decision-making. This session examines the current state and trajectory of new approach methodologies (NAMs) implementation in food ingredient safety evaluation by addressing critical challenges that span the translational pipeline from method development to regulatory acceptance. Central to this discussion is understanding the drivers toward integrating NAMs into safety assessments, including experiences with exposure-based waiving, read-across approaches, physiologically-based kinetic modeling, and in vitro bioactivity assays. In addition, both industry and regulators are confronting practical obstacles such as assessing complex matrices, demonstrating bioavailability and toxicokinetics through non-animal methods, and building regulatory confidence in integrated testing strategies that combine in silico, in vitro, and in chemico approaches. The unique characteristics of food ingredients, including their complex and variable composition, potential for metabolic transformation, and different exposure scenarios, present distinct challenges that require tailored solutions beyond those developed for pharmaceutical or industrial chemical safety assessment. Equally important is exploring how regulatory agencies are strategically advancing NAM qualification and adoption, expanding regulatory science priorities, fostering pre-competitive collaborations that bridge industry, academia, and regulatory science, and developing integrated approaches for testing and assessment into next-generation risk assessment frameworks suitable for food ingredient evaluation. These advances must balance the imperative to embrace innovative science with the responsibility to ensure that new methods are fit-for-purpose, reproducible, and capable of supporting robust safety conclusions. The session will illuminate the spectrum of industry readiness by examining barriers and opportunities for NAM implementation, revealing stakeholder perspectives on regulatory acceptance, confidence in alternative methods, investment priorities, data gaps, and the critical need for harmonized guidance across jurisdictions that can facilitate global market access while reducing duplicative testing. Understanding this landscape from early adopters developing innovative testing strategies to companies seeking clearer regulatory pathways is essential for identifying where targeted support, guidance development, and capacity building are most needed. Together, these perspectives will facilitate dialogue on accelerating the transition toward greater use of NAMs for safety assessment and prioritization of food ingredients while maintaining robust protection of public health and building a more efficient, scientifically advanced, and ethically sound approach to food safety evaluation.

Session and Activity Type
Presentations